[ Price : $8.95]
Federal Register Notice: FDA seeks participants for selecting consumer representatives for the Patient Engagement Advisory Committ...[ Price : $8.95]
Carnegie Mellon researchers say FDAs use of the term breakthrough when discussing the approval of new drugs could be misleading to...[ Price : $8.95]
FDA accepts for priority review an Amgen supplemental NDA for Kyprolis (carfilzomib) for injection for patients with relapsed mult...[ Price : $8.95]
Former Merck general counsel Bruce Kuhlik joins FDA as senior advisor to the commissioner.[ Price : $8.95]
FDA accepts for review an ADMA Biologics BLA for RI-002, and investigational therapy for treating primary immunodeficiency patient...[ Price : $8.95]
Federal Register Notice: FDA establishes the Patient Engagement Advisory Committee to provide advice to the commissioner on issues...[ Price : $8.95]
Federal Register Notice: FDA makes available additional draft and revised draft product-specific bioequivalence recommendations.[ Price : $8.95]
Federal Register Notice: FDAs Pulmonary-Allergy Drugs Advisory Committee will meet 12/9 to discuss a Teva Pharmaceutical BLA to im...